13 research outputs found

    Neuroprogenitor Cells From Patients With TBCK Encephalopathy Suggest Deregulation of Early Secretory Vesicle Transport

    Get PDF
    Biallelic pathogenic variants in TBCK cause encephaloneuropathy, infantile hypotonia with psychomotor retardation, and characteristic facies 3 (IHPRF3). The molecular mechanisms underlying its neuronal phenotype are largely unexplored. In this study, we reported two sisters, who harbored biallelic variants in TBCK and met diagnostic criteria for IHPRF3. We provided evidence that TBCK may play an important role in the early secretory pathway in neuroprogenitor cells (iNPC) differentiated from induced pluripotent stem cells (iPSC). Lack of functional TBCK protein in iNPC is associated with impaired endoplasmic reticulum-to-Golgi vesicle transport and autophagosome biogenesis, as well as altered cell cycle progression and severe impairment in the capacity of migration. Alteration in these processes, which are crucial for neurogenesis, neuronal migration, and cytoarchitecture organization, may represent an important causative mechanism of both neurodevelopmental and neurodegenerative phenotypes observed in IHPRF3. Whether reduced mechanistic target of rapamycin (mTOR) signaling is secondary to impaired TBCK function over other secretory transport regulators still needs further investigation.</jats:p

    Interações medicamentosas: fundamentos para a pratica clínica da enfermagem Drugs interactions: fundamental aspects for clinical practice nursing

    Get PDF
    O fenômeno das interações medicamentosas constitui na atualidade um dos temas mais importantes da farmacologia, para a prática clínica dos profissionais da saúde. O uso concomitante de vários medicamentos, enquanto estratégia terapêutica, e o crescente número destes agentes no mercado são alguns dos fatores que contribuem para ampliar os efeitos benéficos da terapia, mas que também possibilitam a interferência mútua de ações farmacológicas podendo resultar em alterações dos efeitos desejados. Este artigo, de revisão, tem por objetivos rever os princípios farmacológicos relacionados aos mecanismos das interações medicamentosas; descrever as classes dos medicamentos interativos, os grupos de pacientes expostos ao risco e sugerir medidas práticas para a equipe de enfermagem, no intuito de prevenir a ocorrência de reações adversas decorrentes de interações fortuitas.<br>Nowadays drugs interactions constitute one the most important subjects of pharmacological for clinical practive of health professionals. The concomitant use of many drugs as therapeutic strategy and the growing number of agents available contribute to enlarge the benefical effects of therapy. Besides, these factors can also permit the mutual interference of pharmacological actions that result in alteractions of therapeutics effects. The aim of this article is to review the principles pharmacological related to the mechanisms of drugs interactions, to describe the types of interactive drugs; the groups of risk patients and to suggest specific nursing interventions aiming the prevention of occurrence of adverse reactions from accidental interactions
    corecore